Autopsy report · NCT04094181

A Study of VPRIV in Participants With Gaucher Disease Previously Treated With Other Enzyme Replacement Therapies or Substrate Reduction Therapies

“The decision was taken after careful consideration relating to recruitment challenges that could impact the scientific value of the study.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 2 years 2 months before it stopped.
• 2 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Shire

Sponsor type

Industry

Conditions

Gaucher Disease

Participants

2

Sites

1

Countries

Canada

Trials that died the same way

• Imaging Location of Hamstring Muscle Lesions in Sport and Relationships With Injury Mechanism.
  “Reduced recruitment potential for study participants.” (68% match in meaning)
• Intensive Lifestyle Intervention in Patients With Insulin-treated Type 2 Diabetes: a Pilot Project
  “Recruitment was difficult, and the investigator decided to close the study.” (66% match in meaning)
• Evaluate the Safety and Efficacy of Saroglitazar Mg in Patients With Fasting Triglyceride ≥500 mg/dL and ≤1500 mg/dL
  “Management decision to suspend the study due to recruitment issues” (65% match in meaning)
• Safety and Efficacy of the Fruit-based Product OPAL A for the Treatment of Chronic Venous and Pressure Ulcers
  “Slow recruitment caused rethink on the study design” (65% match in meaning)
• The Effect of Ovamax on Oocyte Quality
  “The study was stopped prematurely due to low recruitment rate” (64% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.